Sanofi-Aventis' 2010 Guidance Remains Unchanged; Q1 Sales Up 3.9 %
This article was originally published in The Pink Sheet Daily
Executive Summary
The onset of Lovenox generics could be a near-term reality in the U.S., though timing remains uncertain.